(Q48262149)

PubMed publication ID

25810517

10 February 2018

http://europepmc.org/abstract/MED/25810517

title

Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

0 references

0 references

1 reference

Diana L Castillo-Carranza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

author name string

Marcos J Guerrero-Muñoz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

Urmi Sengupta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

Caterina Hernandez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

Kelly Dineley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

Rakez Kayed

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

Alan D T Barrett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

1 March 2015

1 reference

PubMed publication ID

25810517

10 February 2018

http://europepmc.org/abstract/MED/25810517

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

page(s)

4857-4868

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

describes a project that uses

12 May 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6705372/fullTextXML

inferred from PubMed Central ID database lookup

cites work

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

12 December 2020

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's disease: genes, proteins, and therapy

1 reference

12 December 2020

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

12 December 2020

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

1 reference

12 December 2020

Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins

1 reference

12 December 2020

Tau is essential to beta -amyloid-induced neurotoxicity

1 reference

12 December 2020

Reversible memory loss in a mouse transgenic model of Alzheimer's disease

1 reference

12 December 2020

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

12 December 2020

beta-Amyloid induces paired helical filament-like tau filaments in tissue culture

1 reference

12 December 2020

Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice

1 reference

12 December 2020

Synaptic slaughter in Alzheimer's disease

1 reference

12 December 2020

Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

1 reference

12 December 2020

Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease

1 reference

12 December 2020

Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice.

1 reference

12 December 2020

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

1 reference

12 December 2020

Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.

1 reference

12 December 2020

Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Tau suppression in a neurodegenerative mouse model improves memory function

1 reference

12 December 2020

Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy

1 reference

12 December 2020

Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease.

1 reference

12 December 2020

Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

1 reference

12 December 2020

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

12 December 2020

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Abeta star: a light onto synaptic dysfunction?

1 reference

12 December 2020

Molecular basis of memory loss in the Tg2576 mouse model of Alzheimer's disease.

1 reference

12 December 2020

Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles

1 reference

12 December 2020

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

1 reference

12 December 2020

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers

1 reference

12 December 2020

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

1 reference

12 December 2020

Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

1 reference

12 December 2020

Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model

1 reference

12 December 2020

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

1 reference

12 December 2020

Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function.

1 reference

12 December 2020

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

1 reference

12 December 2020

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis

1 reference

12 December 2020

A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain

1 reference

12 December 2020

Cognitive effects of cell-derived and synthetically derived Aβ oligomers

1 reference

12 December 2020

Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau.

1 reference

12 December 2020

Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice

1 reference

12 December 2020

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

1 reference

12 December 2020

Aβ Oligomers Cause Localized Ca2+Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

1 reference

12 December 2020

Anti-tau oligomers passive vaccination for the treatment of Alzheimer disease

1 reference

12 December 2020

Preparation and characterization of neurotoxic tau oligomers

1 reference

12 December 2020

Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model

1 reference

12 December 2020

Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration

1 reference

12 December 2020

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

1 reference

12 December 2020

Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.

1 reference

12 December 2020

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

1 reference

12 December 2020

AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly

1 reference

12 December 2020

Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression.

1 reference

12 December 2020

Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease

1 reference

12 December 2020

Amyloid-β associated volume loss occurs only in the presence of phospho-tau

1 reference

12 December 2020

Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.

1 reference

12 December 2020

Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice

1 reference

12 December 2020

Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

1 reference

12 December 2020

Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach

1 reference

12 December 2020

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

1 reference

12 December 2020

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

1 reference

12 December 2020

The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease

1 reference

12 December 2020

Soluble aβ promotes wild-type tau pathology in vivo

1 reference

12 December 2020

Tau aggregates as immunotherapeutic targets

1 reference

12 December 2020

Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults

1 reference

12 December 2020

Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity

1 reference

12 December 2020

Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice

1 reference

12 December 2020

Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein

1 reference

12 December 2020

Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation

1 reference

12 December 2020

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy

1 reference

12 December 2020

Breaking the Code of Amyloid-β Oligomers

1 reference

12 December 2020

Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.

1 reference

12 December 2020

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis

1 reference

12 December 2020

Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds

1 reference

12 December 2020

Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.

1 reference

12 December 2020

Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.

1 reference

12 December 2020

p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice

1 reference

12 December 2020

Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

1 reference

12 December 2020

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

1 reference

12 December 2020

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

12 December 2020

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

12 December 2020

10.1523/JNEUROSCI.4989-14.2015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6705372&resulttype=core&format=json

12 May 2020

PubMed publication ID

25810517

1 reference